Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00745368 · ClinicalTrials.gov registry record · NA
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00745368 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 28 participants.
The verdict
NCT00745368, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine how much raltegravir gets into the male and female genital tract.
Interventions
- DRUG Raltegravir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00745368
The ClinicalTrials.gov registry entry for NCT00745368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Raltegravir is the first listed.
NCT00745368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00745368 about?
NCT00745368 is a clinical study titled "Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women". The purpose of this research study is to determine how much raltegravir gets into the male and female genital tract.
What is the current status of trial NCT00745368?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2008-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00745368?
The interventions under investigation include: Raltegravir (DRUG).
Who is sponsoring clinical trial NCT00745368?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.